TRADES
Latest Trades
104
results found
FUND
DATE
ACTION
TICKER
COMPANY
SHARES
% of ETF
ARKG 28 Sep 2021 Sell NVS NOVARTIS AG 320,220 0.3484
ARKG 27 Sep 2021 Sell NVS NOVARTIS AG 107,020 0.1152
ARKG 23 Sep 2021 Sell NVS NOVARTIS AG 157,464 0.1674
ARKG 22 Sep 2021 Sell NVS NOVARTIS AG 241,747 0.2533
ARKG 21 Sep 2021 Sell NVS NOVARTIS AG 94,000 0.0990
ARKG 20 Sep 2021 Sell NVS NOVARTIS AG 37,238 0.0373
ARKG 16 Sep 2021 Sell NVS NOVARTIS AG 57,455 0.0610
ARKG 10 Sep 2021 Sell NVS NOVARTIS AG 59,691 0.0600
ARKG 9 Sep 2021 Sell NVS NOVARTIS AG 229,072 0.2400
ARKG 8 Sep 2021 Sell NVS NOVARTIS AG 193,937 0.2000
ARKG 1 Sep 2021 Sell NVS NOVARTIS AG 32,322 0.0352
ARKG 31 Aug 2021 Sell NVS NOVARTIS AG 142,994 0.1572
ARKG 18 Aug 2021 Sell NVS NOVARTIS AG 52,621 0.0616
ARKG 17 Aug 2021 Sell NVS NOVARTIS AG 30,729 0.0357
ARKG 12 Aug 2021 Sell NVS NOVARTIS AG 92,693 0.1011
ARKG 11 Aug 2021 Sell NVS NOVARTIS AG 86,320 0.0927
ARKG 10 Aug 2021 Sell NVS NOVARTIS AG 53,188 0.0551
ARKG 9 Aug 2021 Sell NVS NOVARTIS AG 100,687 0.1045
ARKG 4 Aug 2021 Sell NVS NOVARTIS AG 133,173 0.1416
ARKG 3 Aug 2021 Sell NVS NOVARTIS AG 143,100 0.1538
ARKG 2 Aug 2021 Sell NVS NOVARTIS AG 76,404 0.0821
ARKG 27 Jul 2021 Sell NVS NOVARTIS AG 47,098 0.0498
ARKG 26 Jul 2021 Sell NVS NOVARTIS AG 60,066 0.0619
ARKG 23 Jul 2021 Sell NVS NOVARTIS AG 242,578 0.2505
ARKK 23 Jul 2021 Sell NVS NOVARTIS AG 216 0.0001
ARKK 22 Jul 2021 Sell NVS NOVARTIS AG 2,800 0.0011
ARKK 21 Jul 2021 Sell NVS NOVARTIS AG 10,000 0.0040
ARKK 20 Jul 2021 Sell NVS NOVARTIS AG 40,000 0.0167
ARKK 19 Jul 2021 Sell NVS NOVARTIS AG 81,600 0.0341
ARKK 16 Jul 2021 Sell NVS NOVARTIS AG 256,150 0.1077
ARKG 15 Jul 2021 Sell NVS NOVARTIS AG 98,887 0.1041
ARKK 15 Jul 2021 Sell NVS NOVARTIS AG 183,740 0.0750
ARKG 14 Jul 2021 Sell NVS NOVARTIS AG 85,913 0.0880
ARKK 13 Jul 2021 Sell NVS NOVARTIS AG 74,815 0.0294
ARKK 12 Jul 2021 Sell NVS NOVARTIS AG 120,883 0.0474
ARKK 7 Jul 2021 Sell NVS NOVARTIS AG 131,960 0.0499
ARKG 17 Jun 2021 Sell NVS NOVARTIS AG 349,532 0.3763
ARKG 16 Jun 2021 Sell NVS NOVARTIS AG 128,903 0.1391
ARKG 15 Jun 2021 Sell NVS NOVARTIS AG 139,576 0.1461
ARKK 14 Jun 2021 Sell NVS NOVARTIS AG 9,409 0.0040
ARKK 11 Jun 2021 Sell NVS NOVARTIS AG 124,596 0.0530
ARKK 10 Jun 2021 Sell NVS NOVARTIS AG 100,388 0.0434
ARKG 2 Jun 2021 Sell NVS NOVARTIS AG 41,594 0.0449
ARKG 26 May 2021 Sell NVS NOVARTIS AG 166,980 0.1814
ARKK 24 May 2021 Sell NVS NOVARTIS AG 44,973 0.0193
ARKK 20 May 2021 Sell NVS NOVARTIS AG 110,405 0.0484
ARKK 19 May 2021 Sell NVS NOVARTIS AG 108,426 0.0485
ARKK 18 May 2021 Sell NVS NOVARTIS AG 152,433 0.0683
ARKK 17 May 2021 Sell NVS NOVARTIS AG 9,910 0.0045
ARKK 13 May 2021 Sell NVS NOVARTIS AG 236,796 0.1112
ARKK 12 May 2021 Sell NVS NOVARTIS AG 179,700 0.0809
ARKK 11 May 2021 Sell NVS NOVARTIS AG 21,128 0.0091
ARKK 7 May 2021 Sell NVS NOVARTIS AG 205,923 0.0877
ARKK 6 May 2021 Sell NVS NOVARTIS AG 234,800 0.1002
ARKG 3 May 2021 Sell NVS NOVARTIS AG 59,216 0.0546
ARKG 29 Apr 2021 Sell NVS NOVARTIS AG 112,985 0.1002
ARKK 28 Apr 2021 Sell NVS NOVARTIS AG 148,180 0.0525
ARKG 21 Apr 2021 Sell NVS NOVARTIS AG 11,038 0.0102
ARKG 20 Apr 2021 Sell NVS NOVARTIS AG 57,600 0.0541
ARKG 19 Apr 2021 Sell NVS NOVARTIS AG 27,353 0.0258
ARKG 30 Mar 2021 Sell NVS NOVARTIS AG 100,127 0.0967
ARKG 29 Mar 2021 Sell NVS NOVARTIS AG 92,709 0.0913
ARKK 25 Mar 2021 Sell NVS NOVARTIS AG 71,063 0.0287
ARKK 4 Mar 2021 Sell NVS NOVARTIS AG 131,888 0.0506
ARKK 1 Mar 2021 Sell NVS NOVARTIS AG 58,657 0.0207
ARKK 26 Feb 2021 Sell NVS NOVARTIS AG 223,902 0.0822
ARKK 25 Feb 2021 Sell NVS NOVARTIS AG 14,692 0.0054
ARKK 12 Feb 2021 Buy NVS NOVARTIS AG 155,469 0.0512
ARKK 11 Feb 2021 Buy NVS NOVARTIS AG 194,772 0.0649
ARKG 10 Feb 2021 Buy NVS NOVARTIS AG 87,684 0.0639
ARKK 10 Feb 2021 Buy NVS NOVARTIS AG 90,902 0.0307
ARKG 9 Feb 2021 Buy NVS NOVARTIS AG 426,773 0.3095
ARKG 8 Feb 2021 Buy NVS NOVARTIS AG 47,803 0.0351
ARKK 8 Feb 2021 Buy NVS NOVARTIS AG 15,467 0.0054
ARKK 5 Feb 2021 Buy NVS NOVARTIS AG 282,125 0.0999
ARKK 4 Feb 2021 Buy NVS NOVARTIS AG 247,057 0.0883
ARKG 3 Feb 2021 Buy NVS NOVARTIS AG 299,907 0.2332
ARKG 2 Feb 2021 Buy NVS NOVARTIS AG 30,705 0.0243
ARKK 29 Jan 2021 Buy NVS NOVARTIS AG 92,187 0.0400
ARKK 28 Jan 2021 Buy NVS NOVARTIS AG 150,052 0.0600
ARKK 26 Jan 2021 Buy NVS NOVARTIS AG 364,291 0.1473
ARKG 21 Jan 2021 Buy NVS NOVARTIS AG 77,165 0.0668
ARKG 20 Jan 2021 Buy NVS NOVARTIS AG 195,595 0.1686
ARKG 19 Jan 2021 Buy NVS NOVARTIS AG 62,491 0.0600
ARKG 15 Jan 2021 Buy NVS NOVARTIS AG 104,619 0.0982
ARKG 14 Jan 2021 Buy NVS NOVARTIS AG 166,098 0.1500
ARKK 13 Jan 2021 Buy NVS NOVARTIS AG 460,412 0.2000
ARKK 12 Jan 2021 Buy NVS NOVARTIS AG 199,208 0.0869
ARKK 11 Jan 2021 Buy NVS NOVARTIS AG 213,392 0.0967
ARKK 8 Jan 2021 Buy NVS NOVARTIS AG 224,573 0.1015
ARKK 7 Jan 2021 Buy NVS NOVARTIS AG 50,104 0.0233
ARKG 4 Jan 2021 Buy NVS NOVARTIS AG 145,574 0.1797
ARKG 30 Dec 2020 Buy NVS NOVARTIS AG-SPONSORED ADR 14,273 0.0200
ARKG 29 Dec 2020 Buy NVS NOVARTIS AG 127,579 0.1602
ARKG 28 Dec 2020 Buy NVS NOVARTIS AG 274,836 0.3254
ARKG 24 Dec 2020 Buy NVS NOVARTIS AG 98,758 0.1127
ARKG 23 Dec 2020 Buy NVS NOVARTIS AG 90,543 0.1050
ARKG 17 Dec 2020 Buy NVS NOVARTIS AG 196,970 0.2987
ARKG 15 Dec 2020 Buy NVS NOVARTIS AG 158,309 0.2423
ARKG 8 Dec 2020 Buy NVS NOVARTIS AG 166,885 0.2897
Latest Blogs
Cathie Wood's ARK Invest sells nearly 34,000 shares of Tesla

On Monday, a large number of shares of an exchange-traded fund (ETF) managed by ETF star Cathie Wood were sold. In particular, this fund sold nearly 34,000 shares of Tesla Inc. (NASDAQ: TSLA), despite the fact that the fund's price had increased by more than 1 percent on the day. It should be noted that the fund has experienced a significant decline over the past year.

 

The ARK Innovation ETF (NYSEARCA: ARKK) was responsible for the sale of 33,919 shares of Tesla. At Monday's closing price, the transaction would have been valued at approximately $34.2 million. Despite the fact that this represents a small portion of the total holdings, every little bit helps. In the last year, the fund has lost 17 percent of its value.

 

Cathie Wood's ARK Transparency ETF (CTRU) is preparing to make its debut on Wednesday, according to the company.

In preparation for Cathie Wood's launch of the ARK Transparency ETF, financial markets are bracing themselves (BATS: CTRU). CTRU is set to launch on Wednesday and will aim to provide investors with exposure to stocks that exhibit the highest levels of transparency, openness, communication, and trust in their operations.

ARK believes that greater transparency fosters greater consumer confidence while also providing investors with long-term growth potential. Because of this, CTRU is designed to track the price movements of the Transparency Index on a continuous basis. The cumulative returns of the S & P 500 and the Transparency Index from October 1, 2016, to September 30, 2021, are depicted in the chart below.

The new fund will have an expense ratio of 0.55 percent, which is lower than the current one. Furthermore, the ETF will have 100 holdings, with the top three holdings being Cloudflare (NYSE: NET), Bloom Energy (NYSE: BE), and Enphase Energy (NYSE: E) (NASDAQ: ENPH). The top holdings and weightings of CTRU are detailed in the fund's fact sheet.

CTRU will be the ninth exchange-traded fund (ETF) launched by ARK Invest and the third index-based ETF. The fund will trade alongside Wood's flagship fund, the ARK Innovation ETF (NYSEARCA: ARKK), which has amassed over $16 billion in assets under management as of the end of September.

The market's reaction to CTRU's unveiling will be determined in due course. If you're interested in a comparison, Wood's most recent ETF launch, the actively managed ARK Space Exploration & Innovation ETF (BATS: ARKX), saw $295 million worth of value traded in its initial public offering on March 30, 2021.

Although her actively managed exchange-traded funds have performed well this year, Wood's newest fund addition will be launched at a time when the sector has been under fire.

 

The Ark of Cathie Wood Invest falls into a bear market as tech bets turn sour.

Ark Invest's flagship Trade-traded fund has seen its losses for the year soar to 26 cents for every dollar invested, as investors sell off the high-growth but typically unprofitable technology stocks that were responsible for the fund's meteoric rise.

Ark Innovation, owned by trader Cathie Wood, opened down four cents on Monday, following a 12.6 cent decrease the previous week, the company's lowest seven-day stretch since February. Since its February high, the ETF has lost more than 40 cents for every dollar invested.

Ark Innovation is a $21.4 billion actively managed exchange-traded fund that invests in corporations in the United States that are pursuing "disruptive innovation," particularly in areas such as DNA systems, automation, robotics, and electrical power storage, synthetic intelligence, and financial technology.

In the past year, some of Ark's most valuable investments have been hammered, including the real estate marketplace Zillow, the virtual health care organization Teladoc, Zoom — the video clip meeting platform that was just one of the big winners of the pandemic — and Roku, a television streaming company.

 

AJ Bell, the UK's second-largest shown spending platform, claimed that "there has been a waning of enthusiasm for higher-growth tech companies." Russ Mould, the company's financial commitment director, said that A large portion of Ark Innovations' holdings is losing money, which is not ideal in an environment when interest rates are expected to climb.

Although Tesla, Ark's lone most prominent position, has recently weakened, its broad 2021 decline would have been substantially worse had it not been for the company's strong performance in 2018. Tesla is up 38 percent this year despite recent weakness.

Ark Innovation, according to Mould, has faced "some inventory-certain concerns, which have exposed some expensive valuations," in addition to risky technology stocks falling out of favor with investors.

Read full article https://www.clearpublicist.com/cathie-woods-ark-invest-slumps-to-bear-market-as-tech-bets-bitter/.